;fill-opacity:1;'/%3e%3cpath%20d='M323.493%2078.6985H312.397L268.767%2023.0136V78.6985H256.027V1.30127H267.123L310.616%2056.9177V1.30127H323.493V78.6985Z'%20fill='white'%20style='fill:white;fill-opacity:1;'/%3e%3cpath%20d='M335.821%2078.6985V1.30127H395.342V13.4931H348.561V33.3561H388.835V45.5478H348.561V66.5067H395.342V78.6985H335.821Z'%20fill='white'%20style='fill:white;fill-opacity:1;'/%3e%3cpath%20d='M423.013%2078.6985H407.671L437.191%2039.452L409.041%201.30127H424.109L444.931%2029.5204L465.89%201.30127H480.959L452.808%2039.5889L482.328%2078.6985H467.054L445.068%2049.7259L423.082%2078.6985H423.013Z'%20fill='white'%20style='fill:white;fill-opacity:1;'/%3e%3c/svg%3e)
Blood Testing
Without the Needle
Painless Laser Diagnostics
Aponex LaserDX is a laser-enabled micro-blood acquisition platform for near-patient diagnostics – built for hospitals, diabetes care, and pediatric workflows across North America.
Get in touch
The Challenge
Fingerstick-based blood diagnostics are painful, fragmented, and ill-suited for high-frequency or sensitive clinical settings.
Collection, analysis, and charting remain disconnected – slowing decisions and adding burden to already stretched clinical staff. For patients in diabetes, pediatric, and clinical care workflows, repeated painful draws erode compliance and comfort overtime.
Our Approach
The Aponex platform replaces the traditional lancet with a minimally invasive pulse that captures micro-volumes of blood at the skin surface – no needle, no pain, no wasted sample.
A modular docking cradle interfaces with cleared predicate analyzers and EMR systems. Starting with Glucose and hemoglobin, the platform is designed to expand analytes over time as clinical evidence builds.
The Device
ORTIV – design by MVITRO Korea, commercialized for North America by Aponex LaserDx
The Cradle
Built for the settings that need it most
From diabetes clinics to NICUs, the Aponex platform addressed the workflows where pain minimization, small sample volumes, and rapid near patient decisions matter most.
Early Traction
U.S. Point-of-care Diagnostics Market
$6.8B
Growing to $10.6B by 2031 – 9.2% CAGR
Anchor Pipeline
20+
Hospitals in active pilot discussions
FQHC Opportunity
30K
Hemoglobin devices identified
The Team
Built by clinicians, engineers, and commercialization experts with deep roots in the UW-Madison ecosystem and global medtech.
Dr. Harpreet Singh
CEO – PhD, Biomedical Engineering
UW-Madison background with NICU and clinical informations commercialization experience. Leads North America operations and commercial strategy
Dr. Ishwara R Sankara
Clinical Advisor – EquipSecond Medical LLC, MD, Neurosciences ICU
Supports the acute-care workflow strategy and shapes the first U.S. clinical and hospital deployment pathways.
Dr. Dongman Lee
Research Advisor – Chair Professor, School of Computing, KAIST
Platform Architecture Lead for next-generation multi-marker, micro-sample blood sensing research.